Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Desmopressin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AVPR1A known ✓ | P37288 | 8/20 | 0.82 |
| ▸ | AVPR2 known ✓ | P30518 | 7/20 | 0.82 |
| ▸ | AVPR1B known ✓ | P47901 | 7/20 | 0.82 |
| ▸ | OXTR | P30559 | 15/20 | 0.82 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.82 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29618038 | 0.94 | OXTR (0.86) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Vasotocin SCHEMBL15511347 | 0.93 | OXTR (0.86) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Argiprestocin SCHEMBL30424966 | 0.93 | OXTR (0.86) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Vasotocin SCHEMBL13331 | 0.93 | OXTR (0.86) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Vasotocin SCHEMBL15511393 | 0.93 | OXTR (0.86) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Oxytocin SCHEMBL28086558 | 0.93 | OXTR (0.93) | OXTRAVPR1AAVPR2AVPR1B | |
| SCHEMBL15511428 | 0.91 | OXTR (0.82) | OXTRAVPR1AAVPR2AVPR1BPTGS1 | |
| Demoxytocin SCHEMBL38443 | 0.91 | AVPR1A (0.88) | OXTRAVPR1AAVPR2AVPR1B | |
| Demoxytocin SCHEMBL29376547 | 0.91 | AVPR1A (0.88) | OXTRAVPR1AAVPR2AVPR1B | |
| Demoxytocin SCHEMBL38442 | 0.91 | AVPR1A (0.88) | OXTRAVPR1AAVPR2AVPR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104940943-B | By spraying with the mucocutaneous attached type preparation of gel-type and the drug delivery system for using it | 东兴药品工业株式会社 | 2019-01-04 | — | — | CN | disclosed |